ROBBIE BOLLINGER: Open Payments
NPI 1457711038 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$866 in 69 payments from 16 companies in 2025. Trend: 2023 $1,576 · 2024 $1,375 · 2025 $866
Food & beverage: $866
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 18 | $197 |
| ABBVIE INC. | 22 | $151 |
| Corium, LLC | 6 | $74 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $68 |
| Novo Nordisk Inc | 3 | $67 |
| Abbott Laboratories | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 2 | $36 |
| Alkermes, Inc. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $20 |
Products named: NURTEC ODT, UBRELVY, ELIQUIS, Azstarys, CAPLYTA, FREESTYLE LIBRE 3, REXULTI, QULIPTA.
Industry payments across OK — which companies pay providers there.
